Declaration of Conflict of Interest. No potential conflict of interest to disclose with regard to the topics of this presentations.

Similar documents
Tobacco Cessation for People with Disabilities. Christopher M. Anderson 2011 Disability and Health Partners Meeting June 14 16, 2011

TWIN VALLEY BEHAVIORAL HEALTHCARE CLINICAL GUIDELINES FOR MANAGEMENT OF SMOKING CESSATION

the high CVD risk smoker

Tobacco Use: Screening & Cessation Intervention

Lucia Cea Soriano 1, Saga Johansson 2, Bergur Stefansson 2 and Luis A García Rodríguez 1*

BASIC SKILLS FOR WORKING WITH SMOKERS

Discontinuation and restarting in patients on statin treatment: prospective open cohort study using a primary care database

Do Not Cite. Draft for Work Group Review.

BASIC SKILLS FOR WORKING WITH SMOKERS

Population-level Strategies to Prevent and Reduce Tobacco Use Success and Challenge

Real-World Data for Enhancement of a National Smoking Cessation Intervention

The Impact of Smoking on Acute Ischemic Stroke

Smoking Cessation at Bladder Cancer Diagnosis: Many Patients Might Benefit from this Teachable Moment

Sleep Problems and Smoking Cessation in Women

Supplementary Online Content

Measure #402: Tobacco Use and Help with Quitting Among Adolescents National Quality Strategy Domain: Community / Population Health

Smoking Cessation Interventions In Hospital Settings: Implementing the Evidence

The importance of follow-up after a cardiac event: CARDIAC REHABILITATION. Dr. Guy Letcher

Smoking Cessation: Good News at Last!

10-Year Mortality of Older Acute Myocardial Infarction Patients Treated in U.S. Community Practice

UMASS TOBACCO TREATMENT SPECIALIST CORE TRAINING

TOBACCO TREATMENT INPATIENT QUALITY MEASURES. Kathy Wonderly RN, MSEd, CPHQ Consultant Developed: December 2015

Smoking cessation: the value of working together. Dr Donita Baird and Dr Sarah L White

Effective Treatments for Tobacco Dependence

Smoking cessation interventions and services

A multicenter tobacco cessation program in acute coronary syndrome

Successful Cessation: Exploring Quit Attempts at Lehigh Valley Hopital's Tabacco Treatment Program.

Appendix: Supplementary tables [posted as supplied by author]

Transient Atrial Fibrillation and Risk of Stroke after Acute Myocardial Infarction

Supplementary Online Content

ISCHEMIC VASCULAR DISEASE (IVD) MEASURES GROUP OVERVIEW

Development, Implementation, and Dissemination of the Nurse-Administered Tobacco Tactics Intervention

Tobacco and Tuberculosis:

AHEC Tobacco Online Modules

The 5A's are practice guidelines on tobacco use prevention and cessation treatment (4):

Smoke-free Hospitals. Linda A. Thomas, MS University of Michigan Health System Tobacco Consultation Service

CORONARY ARTERY DISEASE (CAD) MEASURES GROUP OVERVIEW

Does quality of life predict morbidity or mortality in patients with atrial fibrillation (AF)?

A Tobacco Cessation Initiative by:

Smoking Cessation in Pregnancy. Jessica Reader, MD, MPH Family Medicine Obstetrics Fellow June 1st, 2018

Performance Outcomes: Measure & Metric Details

NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE SCOPE

Smoking Status and Body Mass Index in the United States:

Steps Against Recurrent Stroke (STARS)

Smoking Counselling and Cessation Service in Hospital Authority 7 May HA Convention 2014

GSK Medicine: Study Number: Title: Rationale: Phase: Study Period: Study Design: Centres: Indication: Treatment: Objectives:

The Vancouver General Hospital Smoking Cessation Clinic: Outcomes from a Specialist Cessation Service within Cardiology

EVIDENCE-BASED INTERVENTIONS TO HELP PATIENTS QUIT TOBACCO

Smoking Cessation: Where Are We Now? Nancy Rigotti, MD

Supplemental table 1. Dietary sources of protein among 2441 men from the Kuopio Ischaemic Heart Disease Risk Factor Study MEAT DAIRY OTHER ANIMAL

Understanding Risk Factors for Stroke

Supplementary Online Content

Helping Nurses Help Smokers Quit. Beth Allison, FNP BC OHSU Smoking Cessation Center & Tobacco Consult Service

NIH Public Access Author Manuscript JAMA Intern Med. Author manuscript; available in PMC 2014 June 24.

Building Capacity for Smoking Cessation Treatment Within Primary Care Teams

Updates to Advanced Certification for Primary Stroke Centers and Advanced Certification in Heart Failure

Wanting to Get Pregnant

Varenicline and cardiovascular and neuropsychiatric events: Do Benefits outweigh risks?

115 remained abstinent. 140 remained abstinent. Relapsed Remained abstinent Total

Cardiovascular Health Practice Guideline Outpatient Management of Coronary Artery Disease 2003

Redgrave JN, Coutts SB, Schulz UG et al. Systematic review of associations between the presence of acute ischemic lesions on

Race Original cohort Clean cohort HR 95%CI P HR 95%CI P. <8.5 White Black

Long-term prognostic value of N-Terminal Pro-Brain Natriuretic Peptide (NT-proBNP) changes within one year in patients with coronary heart disease

QStatin Update Information

Supplementary Table S1: Proportion of missing values presents in the original dataset

Supplementary Online Content

Steps Against Recurrent Stroke (STARS)

Smoking cessation interventions and services

Tobacco Use and Reproductive Health: An Update

Mean INTERHEART Risk Score (IHRS) Yusuf et al NEJM 2014

Clinical Study Synopsis

Tobacco-related deaths and disabilities are on

GSK Medicine: Study No.: Title: Rationale: before initiation of treatment, every 4-6 weeks during treatment

Implementation Strategy

Quitting patterns and success rates of a tobacco cessation program led by New Mexico Pharmaceutical Care Foundation

ATTUD APPLICATION FORM FOR WEBSITE LISTING (PHASE 1): TOBACCO TREATMENT SPECIALIST (TTS) TRAINING PROGRAM PROGRAM INFORMATION & OVERVIEW

Nicotine Replacement and Smoking Cessation: Update on Best Practices

A systems approach to treating tobacco use and dependence

Brief Intervention (BI) for Adolescents

PolyU - Henry G. Leong Mobile Integrative Health Centre. PolyU - Henry G. Leong Mobile Integrative Health Centre MONTHLY REPORT

IOWA MEDICAID DRUG UTILIZATION REVIEW COMMISSION 100 Army Post Road Des Moines, IA (515) Fax

A randomized trial comparing two Internetbased smoking cessation programs

GALECTIN-3 PREDICTS LONG TERM CARDIOVASCULAR DEATH IN HIGH-RISK CORONARY ARTERY DISEASE PATIENTS

NORTH CAROLINA CARDIOVASCULAR STATE PLAN I N T R O D U C T I O N S, G O A L S, O B J E C T I V E S A N D S T R A T E G I E S

Page 1 of 11. Effective 9/15/2018 AUTHORIZATION REQUIREMENT LEVEL OF CARE. Notes (0 = No Additional Comments)

The University of Mississippi School of Pharmacy

The pilot objectives smoking cessation

NQF Behavioral Health Project Phase II Submitted Measures

Presenter Disclosure Information Karine Sahakyan, MD, PhD, MPH

Non-Compliance with Guidelines: Motivations and Consequences in a case study. The ischemic stroke management

Supplementary Online Content

Evaluation of a smoking cessation intervention for pregnant women in an urban prenatal clinic

Supplementary Methods

Pharmacotherapy for Tobacco Dependence Treatment

Looking Toward State Health Assessment.

HCV care after cure. This program is supported by educational grants from

Tobacco Treatment Measures KATHY WONDERLY RN, MSED, CPHQ CONSULTANT DEVELOPED: JANUARY 2018

Impact of the Tips from Former Smokers 2012 Campaign on Awareness and Use of Cessation Resources

Person-years; number of study participants (number of cases) HR (95% CI) P for trend

Smoking Cessation. Disclosures. Thank You. None

Transcription:

Declaration of Conflict of Interest No potential conflict of interest to disclose with regard to the topics of this presentations.

Clinical implications of smoking relapse after acute ischemic stroke Furio Colivicchi, Andrea Bassi*, Massimo Santini, Carlo Caltagirone* Cardiovascular Department, S. Filippo Neri Hospital, Rome, ITALY *Clinical Research Institute, S. Lucia Foundation, Rome, ITALY

Background and Aim of the Study Cigarette smoking is a major risk factor for stroke and healthcare providers should advise every patient with stroke who has smoked in the past year to quit. However, smoking relapse is frequent, even after an admission for a major acute cardiovascular event. Aim of this study was to evaluate the smoking relapse rate among smokers who had become abstinent during admission for ischemic stroke. Moreover, the association between smoking relapse and mortality has also been analysed.

Study Population 921 consecutive active smokers who had completely interrupted smoking since admission for ischemic stroke (584 men and 337 women, mean age 67 ± 16 years) were followed for 12 months after the index event. All patients received a brief in-hospital smoking cessation intervention consisting of repeated counseling sessions lasting 5-20 minutes. No specific post-discharge support was used in any case. No pharmacotherapy for smoking cessation was prescribed in any case

Follow-up A follow-up period of 12 months after the index acute event was planned for all patients. The primary end point of the study was death from any cause within 12 months of discharge. Adherence to recommended lifestyle modifications, including smoking cessation, was assessed by telephone interviews at 1, 6, and 12 months after discharge. The interviews were conducted by a trained nurse. In the case of failure to interview the patient, all relevant data, including survival and smoking status, were collected from primary care physicians, who are responsible for clinical follow-up and prescription refilling in the Italian National Health Service.

Relapsed Smokers (%) Relapse curve showing the occurrence of smoking relapse in the study population. During the 12-month follow-up period 493 patients (53.5%) resumed regular smoking (median interval to relapse 21 days, interquartile range 10 to 84). Time (days)

Study Population Characteristics Total Cohort (n=921) Relapsed Smokers (n=493) Abstinent (n=428) Age (years) 67±16 69±16* 65±15 Women 337 (36%) 216 (44%)* 121 (28%) NIH stroke scale score 9.1±2.7 9.0±2.8 9.1±2.6 Obesity 189 (20%) 98 (20%) 91 (21%) Hypertension 634 (69%) 346 (70%) 288 (68%) Previous Stroke 103 (11%) 59 (12%) 44 (10%) Previous MI 167 (18%) 95 (19%) 72 (16%) Atrial Fibrillation 136 (14%) 74 (15%) 62 (14%) Heart Failure 84 (9%) 50 (10%) 34 (8%) CKD 106 (12%) 65 (13%) 41 (9%) * p<0.001

Smoking Cessation Interventions Total Cohort (n=921) Relapsed Smokers (n=493) Abstinent (n=428) Counseling delivered by nurse 672 (73%) 364 (74%) 308 (71%) Counseling delivered by physician 249 (27%) 129 (26%) 120 (29%) Hospital-based rehabilitation program after stroke 313 (34%) 123 (25%)* 190 (44%) * p<0.001

Smoking Relapse Predictors Independent predictors of relapse by multivariate analysis (Cox proportional hazard regression method): 1. Increasing age (HR 1.048 per year, 95% CI 1.021 to 1.074, p=0.02) 2. Female gender (HR 1.38, 95% CI 1.11 to 1.48, p=0.01) 3. Hospital-based rehabilitation program (HR 0.64, 95% CI 0.49 to 0.87, p=0.01)

12-month Outcome During the 12-month follow-up, 89 patients died (9.6%, 95% CI 4.9 to 8.8). Cardiovascular death in 79 patients (88.7%). Multivariate analysis with the Cox proportional hazard regression method, including smoking relapse as a timedependent covariate, demonstrated that after adjustment (demographics, clinical history, and variables related to the index event), resumption of smoke was an independent predictor of total mortality. An earlier smoking relapse was associated with a greater risk of death.

Multivariable adjusted hazard ratios over time (with horizontal bars representing the 95% confidence intervals) for the association between smoking relapse and all-cause mortality

Conclusions Smoking cessation programs using solely brief individual counseling without post-discharge followup may be associated with a high smoking relapse rate. Post-discharge rehabilitation reduces the risk of smoking relapse (36% RRR). Smoking relapse after ischemic stroke is associated with a significant increase in all-cause mortality. An earlier resumption imparts a greater risk of death compared to a later relapse of tobacco smoking.